Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
rates decrease » rate decreased (Expand Search), greater decrease (Expand Search), ratio decreased (Expand Search)
Showing 281 - 300 results of 14,815 for search '(( significant ((rates decrease) OR (greatest decrease)) ) OR ( significant increase decrease ))', query time: 0.56s Refine Results
  1. 281
    Counts and age-standardized rate of gastric adenocarcinoma incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race.

    Counts and age-standardized rate of gastric adenocarcinoma incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 282
    Counts and age-standardized rate of signet ring carcinoma incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race.

    Counts and age-standardized rate of signet ring carcinoma incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race. by Armin Aslani (13009188)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 283
    Counts and age-standardized rate of gastrointestinal stromal tumor incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and race.

    Counts and age-standardized rate of gastrointestinal stromal tumor incidence per 100,000 and average annual percent change from 2000 to 2019 in the United States, by age, sex, and... by Armin Aslani (13009188)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 284
    Fig 1 -

    Fig 1 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 285
    Fig 8 -

    Fig 8 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 286
    Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells.

    Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 287
    Fig 4 -

    Fig 4 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 288
    Fig 9 -

    Fig 9 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 289
    Trypan blue dye exclusion assay for cell viability evaluation (% of control).

    Trypan blue dye exclusion assay for cell viability evaluation (% of control). by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 290
    Fig 7 -

    Fig 7 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 291
    Fig 10 -

    Fig 10 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 292
    Fig 5 -

    Fig 5 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 293
    Fig 6 -

    Fig 6 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 294
    Joinpoint regression trends in crude hospitalization and mortality rates of HPV-associated cancers in Mexico (2011–2019).

    Joinpoint regression trends in crude hospitalization and mortality rates of HPV-associated cancers in Mexico (2011–2019). by Juan Carlos Orengo (21546581)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 295
    Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021.

    Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 296
    Contrasting Size Dependence of Photochemical Lifetimes of Polypropylene and Expanded Polystyrene Microplastics in Surface Waters

    Contrasting Size Dependence of Photochemical Lifetimes of Polypropylene and Expanded Polystyrene Microplastics in Surface Waters by Ariana Patterson (22764051)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 297
    Evolution of health burden and life expectancy under different expenditure scenarios.

    Evolution of health burden and life expectancy under different expenditure scenarios. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 298
    Scaling of overall health burden with yearly expenditure growth.

    Scaling of overall health burden with yearly expenditure growth. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 299
    Impact on different areas of health.

    Impact on different areas of health. by Margherita Molaro (17803989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 300
    Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI.

    Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: